Aims/hypothesis The two-pore domain K+ channel TWIK1-related alkalinisation-activated K+ channel 2 (TALK-2) is encoded by KCNK17, which is one of the most abundant beta cell K+ channel transcripts that also shows high islet expression specificity. Polymorphisms that increase islet KNCK17 expression or result in TALK-2 gain-of-function are associated with a predisposition for developing type 2 diabetes. However, there is a gap in knowledge of the beta cell function(s) of TALK-2. As K+ channels typically control beta cell Ca2+ handling, we aimed to examine the TALK-2 channel control of beta cell Ca2+ homeostasis and the resulting impact on insulin secretion. Methods Localisation of TALK-2 was evaluated with immunofluorescent staining as well as TALK-2-GFP construct co-expressed with intracellular markers. TALK-2 function was evaluated by measuring changes in cytoplasmic Ca2+ (Ca2+C), endoplasmic reticulum Ca2+ (Ca2+ER), ER membrane potential (Vm), K+ currents and insulin secretion in a TALK-2 inducible cell line and/or primary human beta cells with adenoviral-mediated shRNA knockdown (KD) of TALK-2 or scramble shRNA. Results TALK-2 protein localised to the plasma membrane and ER membrane, and formed functional channels on the ER membrane. Ca2+ER release was accelerated by TALK-2 (slope for TALK-2-expressing cells vs controls: 14.8 ± 0.7 vs 8.9 ± 1.3, respectively, shown as mean ± SE), which reduced Ca2+ER storage (ΔCa2+ER amplitude: TALK-2-expressing cells reduced by 25 ± 5%) and increased basal relative Ca2+C (fold increase by 12 ± 2%). Furthermore, TALK-2 diminished ER membrane hyperpolarisation following Ca2+ER release (Accelerated Sensor of Action Potentials [ASAP3ER] amplitude decreased by 20 ± 0.8% in TALK-2-expressing cells), suggesting that TALK-2 strengthens the electrical driving force for Ca2+ER leak. In human beta cells, TALK-2-KD increased Ca2+ER stores by reducing Ca2+ER leak (2.30 ± 0.12 vs controls 2.65 ± 0.14). Moreover, TALK-2-KD reduced beta cell Ca2+C at euglycaemic conditions (2.88 ± 0.36 vs controls 3.16 ± 0.36) and increased beta cell Ca2+C influx in response to hyperglycaemic conditions (4.07 ± 0.55 vs controls 3.45 ± 0.48). Human pseudoislets with beta cell-specific TALK-2-KD displayed reduced basal insulin secretion (0.266 ± 0.065 vs controls 0.432 ± 0.073) and enhanced glucose-stimulated insulin secretion (GSIS; 85.01 ± 13.96 vs controls 42.53 ± 5.52). Conclusions/interpretation These data support the notion that TALK-2 functions on the human beta cell ER membrane to increase the electrical driving force for beta cell Ca2+ER release, reduces glucose-stimulated Ca2+ influx and limits GSIS. Furthermore, TALK-2-mediated amplification of Ca2+ER leak likely enhances basal insulin secretion by increasing Ca2+C. Therefore, polymorphisms in KCNK17 that increase TALK-2 activity or expression would be predicted to increase type 2 diabetes risk by blunting beta cell glucose-stimulated Ca2+ influx, limiting GSIS, promoting Ca2+ER leak and elevating basal insulin secretion. Graphical Abstract

The diabetes-associated K⁺ channel TALK-2 controls human beta cell endoplasmic reticulum Ca²⁺ handling, which promotes basal insulin release and limits glucose-stimulated insulin secretion

期刊论文
出版模式：

开放获取
发表日期：

2026年2月25日

查看全文

Jordyn R. Dobson,
Prasanna K. Dadi,
Matthew T. Dickerson,
Arya Y. Nakhe,
Soma Behera,
Shannon E. Gibson,
Spencer J. Peachee,
Anthony Piron,
Miriam Cnop,
David A. Jacobson

摘要

Aims/hypothesis

The two-pore domain K⁺ channel TWIK1-related alkalinisation-activated K⁺ channel 2 (TALK-2) is encoded by KCNK17, which is one of the most abundant beta cell K⁺ channel transcripts that also shows high islet expression specificity. Polymorphisms that increase islet KNCK17 expression or result in TALK-2 gain-of-function are associated with a predisposition for developing type 2 diabetes. However, there is a gap in knowledge of the beta cell function(s) of TALK-2. As K⁺ channels typically control beta cell Ca²⁺ handling, we aimed to examine the TALK-2 channel control of beta cell Ca²⁺ homeostasis and the resulting impact on insulin secretion.

Methods

Localisation of TALK-2 was evaluated with immunofluorescent staining as well as TALK-2-GFP construct co-expressed with intracellular markers. TALK-2 function was evaluated by measuring changes in cytoplasmic Ca²⁺ (Ca²⁺_C), endoplasmic reticulum Ca²⁺ (Ca²⁺_ER), ER membrane potential (V_m), K⁺ currents and insulin secretion in a TALK-2 inducible cell line and/or primary human beta cells with adenoviral-mediated shRNA knockdown (KD) of TALK-2 or scramble shRNA.

Results

TALK-2 protein localised to the plasma membrane and ER membrane, and formed functional channels on the ER membrane. Ca²⁺_ER release was accelerated by TALK-2 (slope for TALK-2-expressing cells vs controls: 14.8 ± 0.7 vs 8.9 ± 1.3, respectively, shown as mean ± SE), which reduced Ca²⁺_ER storage (ΔCa²⁺_ER amplitude: TALK-2-expressing cells reduced by 25 ± 5%) and increased basal relative Ca²⁺_C (fold increase by 12 ± 2%). Furthermore, TALK-2 diminished ER membrane hyperpolarisation following Ca²⁺_ER release (Accelerated Sensor of Action Potentials [ASAP3_ER] amplitude decreased by 20 ± 0.8% in TALK-2-expressing cells), suggesting that TALK-2 strengthens the electrical driving force for Ca²⁺_ER leak. In human beta cells, TALK-2-KD increased Ca²⁺_ER stores by reducing Ca²⁺_ER leak (2.30 ± 0.12 vs controls 2.65 ± 0.14). Moreover, TALK-2-KD reduced beta cell Ca²⁺_C at euglycaemic conditions (2.88 ± 0.36 vs controls 3.16 ± 0.36) and increased beta cell Ca²⁺_C influx in response to hyperglycaemic conditions (4.07 ± 0.55 vs controls 3.45 ± 0.48). Human pseudoislets with beta cell-specific TALK-2-KD displayed reduced basal insulin secretion (0.266 ± 0.065 vs controls 0.432 ± 0.073) and enhanced glucose-stimulated insulin secretion (GSIS; 85.01 ± 13.96 vs controls 42.53 ± 5.52).

Conclusions/interpretation

These data support the notion that TALK-2 functions on the human beta cell ER membrane to increase the electrical driving force for beta cell Ca²⁺_ER release, reduces glucose-stimulated Ca²⁺ influx and limits GSIS. Furthermore, TALK-2-mediated amplification of Ca²⁺_ER leak likely enhances basal insulin secretion by increasing Ca²⁺_C. Therefore, polymorphisms in KCNK17 that increase TALK-2 activity or expression would be predicted to increase type 2 diabetes risk by blunting beta cell glucose-stimulated Ca²⁺ influx, limiting GSIS, promoting Ca²⁺_ER leak and elevating basal insulin secretion.

Graphical Abstract

The diabetes-associated K+ channel TALK-2 controls human beta cell endoplasmic reticulum Ca2+ handling, which promotes basal insulin release and limits glucose-stimulated insulin secretion

摘要

The diabetes-associated K⁺ channel TALK-2 controls human beta cell endoplasmic reticulum Ca²⁺ handling, which promotes basal insulin release and limits glucose-stimulated insulin secretion